Janux Therapeutics, Inc. SEC filings JANX
Janux Therapeutics, Inc. has 442 filings in SEC EDGAR's recent list, going back to Jul 14, 2020. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Feb 26, 2026 | — |
| S-8 | Employee stock plan registration | Feb 27, 2025 | — |
| 424B5 | Prospectus supplement | Dec 5, 2024 | — |
| 424B5 | Prospectus supplement | Dec 3, 2024 | — |
| S-3ASR | Automatic shelf registration | May 8, 2024 | — |
| S-8 | Employee stock plan registration | Mar 8, 2024 | — |
| 424B5 | Prospectus supplement | Feb 29, 2024 | — |
| FWP | Free writing prospectus | Feb 29, 2024 | — |
| 424B5 | Prospectus supplement | Feb 28, 2024 | — |
| 424B5 | Prospectus supplement | Jul 18, 2023 | — |
| FWP | Free writing prospectus | Jul 17, 2023 | — |
| 424B5 | Prospectus supplement | May 9, 2023 | — |
| S-8 | Employee stock plan registration | Mar 10, 2023 | — |
| S-3 | Shelf registration | Aug 9, 2022 | — |
| S-8 | Employee stock plan registration | Mar 18, 2022 | — |
| S-8 | Employee stock plan registration | Jun 11, 2021 | — |
| 424B4 | Prospectus | Jun 11, 2021 | — |
| S-1MEF | Filing | Jun 10, 2021 | — |
| S-1/A | Amended registration statement | Jun 7, 2021 | — |
| S-1 | Registration statement | May 19, 2021 | — |
Showing 20 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- JANX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1817713
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.